The Global Ophthalmology Awards Program demonstrates Bayer's commitment to the ophthalmology community and to advancing state of the art ophthalmic care. As award decisions are taken by the independent Grants Review and Awards Committee, and based on an applicant’s merit and eligibility, all decisions are final and not subject to appeal.
This award supports a wide range of clinical and basic research projects in the field of retinal ophthalmology, such as diagnosis and assessment, surgery, quality of life, mechanisms of action, novel therapeutic approaches and disease pathophysiology.
Applicants must have an MD and/or a PhD, and be affiliated with a faculty that carries out research in ophthalmology. Additionally, at the time of application, it is strongly preferred that applicants have received their ophthalmology specialist qualification within the past 10 years or are currently in training towards receiving it; PhD applicants should have received their PhD qualification within the past 10 years when they apply.
Applicants will be judged according to the following criteria:
- Merit - Scientific merit of the experimental approach and its relevance to the ophthalmology/research community
- Innovation - Novelty of the study design, methodology and objectives
- Impact - Impact on clinical or scientific understanding of retinal disorders
- Environment - Quality of the research environment
Research Awards will provide funding of up to US$50,000 per award for one year in the majority of cases. Additional funding will be considered, but must be justified.
Payment must be made to the awardee's institution rather than directly to the awardee.